期刊文献+

Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial 被引量:10

Protective effect of Xuebijing injection on myocardial injury in patients with sepsis: a randomized clinical trial
原文传递
导出
摘要 OBJECTIVE: To investigate the protective effect and possible mechanism of Xuebijing Injection on myocardial injury in patients with sepsis, and to evaluate its prognostic implications.METHODS: Patients with septic myocardial injury were recruited, and were randomly divided into two groups: treatment group and control group. All patients in two groups received conventional cluster treatment, the patients in treatment group additional received Xuebijing injection dissolved in0.9% sodium chloride injection, and the patients in control group received the same amount of 0.9%sodium chloride injection. At the beginning of treatment and 3, 7 and 10-day after treatment, lab-oratory indicators of cardiac troponin Ⅰ(cTnI),N-terminal pro B-type natriuretic peptide(NT-pro BNP) and procalcitonin(PCT) were respectively tested in venous blood. The patient's length of stay in Intensive Care Unit(ICU) and the mortality in 28 days were recorded.RESULTS: At 3, 7 and 10-day after treatment, the improvements of c Tn I, NT-pro BNP and PCT in treatment group were better than those in control group, and the differences were statistically significant(P < 0.05). The mortality of treatment group in28 days was not significantly different from that of control group(P > 0.05). The ICU length of stay of treatment group was shorter than that of control group(P > 0.05).CONCLUSION: Xuebijing injection could improve the levels of c Tn I, NT-pro BNP and PCT in patients with septic myocardial injury.and it had a protective effect on myocardial injury. OBJECTIVE: To investigate the protective effect and possible mechanism of Xuebijing Injection on myocardial injury in patients with sepsis, and to evaluate its prognostic implications.METHODS: Patients with septic myocardial injury were recruited, and were randomly divided into two groups: treatment group and control group. All patients in two groups received conventional cluster treatment, the patients in treatment group additional received Xuebijing injection dissolved in0.9% sodium chloride injection, and the patients in control group received the same amount of 0.9%sodium chloride injection. At the beginning of treatment and 3, 7 and 10-day after treatment, lab-oratory indicators of cardiac troponin Ⅰ(cTnI),N-terminal pro B-type natriuretic peptide(NT-pro BNP) and procalcitonin(PCT) were respectively tested in venous blood. The patient’s length of stay in Intensive Care Unit(ICU) and the mortality in 28 days were recorded.RESULTS: At 3, 7 and 10-day after treatment, the improvements of c Tn I, NT-pro BNP and PCT in treatment group were better than those in control group, and the differences were statistically significant(P 〈 0.05). The mortality of treatment group in28 days was not significantly different from that of control group(P 〉 0.05). The ICU length of stay of treatment group was shorter than that of control group(P 〉 0.05).CONCLUSION: Xuebijing injection could improve the levels of c Tn I, NT-pro BNP and PCT in patients with septic myocardial injury.and it had a protective effect on myocardial injury.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2016年第6期706-710,共5页 中医杂志(英文版)
基金 Supported by Key Medical Research Subject of Hebei Province(the Protective Effect and Mechanism of Xuebijing Injection on Cardiac Function in Patients With Sepsis,No.ZD20140379)
关键词 SEPSIS Myocardial reperfusion injury Cardiac troponin Pro-brain natriuretic peptide(1-76) PROCALCITONIN Randomized clinical trials Xuebijing injection Sepsis Myocardial reperfusion injury Cardiac troponin Ⅰ Pro-brain natriuretic peptide(1-76) Procalcitonin Randomized clinical trials Xuebijing injection
  • 相关文献

参考文献2

二级参考文献35

  • 1高红梅,常文秀,曹书华.“血必净”注射液对内毒素刺激的内皮细胞的影响[J].中国急救医学,2005,25(6):437-438. 被引量:95
  • 2梁显泉,李志军,刘红栓,王今达.血必净注射液治疗脓毒症42例[J].中国中西医结合急救杂志,2005,12(4):251-252. 被引量:107
  • 3朱雪琦,王蕾,刘清泉,姚咏明.血必净注射液对脓毒症大鼠肾保护作用的研究[J].中国危重病急救医学,2006,18(11):680-683. 被引量:44
  • 4Angus DC, Linde - Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care [ J ] . Crit Care Med, 2001,29 ( 7 ) : 1303 - 1310.
  • 5Rangel - Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS) : a prospective study[ J ]. JAMA, 1995, 273 (2) : 117 - 123.
  • 6American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [ J]. Crit Care Med, 1992, 20(6) :864 -874.
  • 7Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis[ J]. N Engl J Med, 2001, 344(10) : 699 -709.
  • 8Karen E, Welty - Wolf, Martha S, et al. Blockade of tissue factor - factor X binding attenuates sepsis - induced respiratory and renal failure [ J ]. Am J Physiol Lung Cell Mol Physiol,2006, 290 ( 1 ) : L21 - 31.
  • 9Marcel Levi, van der Poll, Harry R, et al. Bidirectional relation between inflammation and coagulation [ J ]. Circulation, 2004, 109 ( 22 ) :2698 - 2704.
  • 10Vincent JL, Sakr Y, Sprung CL, et al. Sepsis occurrence in acutely ill patients investigators, sepsis in European intensive care units: results of the SOAP study[J]. Crit Care Med, 2006, 34 (2) : 344-353.

共引文献105

同被引文献189

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部